6-methanesulfonyl-1-methyl-3-tributylstannanyl-1H-indazole → 2-(6-methanesulfonyl-1-methyl-1H-indazol-3-yl)-5-(2-trimethylsilanyl-ethoxymethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid tert-butylamide

Participants

Reaction Conditions

Reaction Steps

In a round-bottomed flask, 2-bromo-5-(2-trimethylsilanyl-ethoxymethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid tert-butylamide (110 mg, 0.26 mmol) and 6-methanesulfonyl-1-methyl-3-tributylstannanyl-1H-indazole (crude from Step 3, 330 mg, 0.33 mmol) were dissolved in DMF (1.7 ml). The flask was evacuated and backfilled with argon and tetrakis(triphenylphosphine)palladium (0) (15 mg, 0.013 mmol) and copper (I) iodide (10 mg, 0.053 mmol) were added. The reaction mixture was stirred at 90° C. for 3 h then allowed to cool to room temperature overnight. The reaction was quenched with water and extracted with diethyl ether (2×) and EtOAc. The combined organic layers were washed twice with water and once with brine then dried over sodium sulfate, filtered and concentrated. The residue was chromatographed over 25 g silica gel with EtOAc/hexanes (gradient: 0-40% EtOAc) to afford 79 mg (55%) of 2-(6-methanesulfonyl-1-methyl-1H-indazol-3-yl)-5-(2-trimethylsilanylethoxymethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid tert-butylamide as a light brown solid.

Provenance & Evidence